nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—Microtubule Inhibition—Paclitaxel—ovarian cancer	0.227	1	CiPCiCtD
Docetaxel—Paclitaxel—ovarian cancer	0.213	1	CrCtD
Docetaxel—Cabazitaxel—Paclitaxel—ovarian cancer	0.123	1	CrCrCtD
Docetaxel—breast cancer—ovarian cancer	0.112	1	CtDrD
Docetaxel—TUBB3—ovarian cancer	0.0509	0.501	CbGaD
Docetaxel—CYP1B1—ovarian cancer	0.0227	0.224	CbGaD
Docetaxel—EGFR—ovarian cancer	0.0215	0.211	CbGaD
Docetaxel—MAP4—Paclitaxel—ovarian cancer	0.0132	0.0861	CbGbCtD
Docetaxel—MAPT—Paclitaxel—ovarian cancer	0.00957	0.0623	CbGbCtD
Docetaxel—MAP2—Paclitaxel—ovarian cancer	0.00957	0.0623	CbGbCtD
Docetaxel—BCL2—Paclitaxel—ovarian cancer	0.0076	0.0495	CbGbCtD
Docetaxel—ABCB1—ovarian cancer	0.00653	0.0642	CbGaD
Docetaxel—TUBB6—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB3—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB8—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB2A—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB4A—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB2B—Vinorelbine—ovarian cancer	0.00621	0.0404	CbGbCtD
Docetaxel—TUBB4B—Vinorelbine—ovarian cancer	0.0052	0.0338	CbGbCtD
Docetaxel—TUBB1—Vinorelbine—ovarian cancer	0.0052	0.0338	CbGbCtD
Docetaxel—TUBB—Vinorelbine—ovarian cancer	0.0052	0.0338	CbGbCtD
Docetaxel—TUBB3—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—TUBB2A—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—TUBB6—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—TUBB8—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—TUBB4A—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—TUBB2B—Paclitaxel—ovarian cancer	0.00437	0.0284	CbGbCtD
Docetaxel—NR1I2—Paclitaxel—ovarian cancer	0.00397	0.0259	CbGbCtD
Docetaxel—TUBB—Paclitaxel—ovarian cancer	0.00365	0.0238	CbGbCtD
Docetaxel—TUBB4B—Paclitaxel—ovarian cancer	0.00365	0.0238	CbGbCtD
Docetaxel—TUBB1—Paclitaxel—ovarian cancer	0.00365	0.0238	CbGbCtD
Docetaxel—ABCC10—Paclitaxel—ovarian cancer	0.00279	0.0182	CbGbCtD
Docetaxel—SLCO1B3—Paclitaxel—ovarian cancer	0.00156	0.0101	CbGbCtD
Docetaxel—CYP1B1—Paclitaxel—ovarian cancer	0.00152	0.00987	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—ovarian cancer	0.0015	0.00979	CbGbCtD
Docetaxel—ABCG2—Topotecan—ovarian cancer	0.00146	0.00948	CbGbCtD
Docetaxel—ABCC1—Epirubicin—ovarian cancer	0.00109	0.00711	CbGbCtD
Docetaxel—ABCC1—Paclitaxel—ovarian cancer	0.00108	0.00701	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—ovarian cancer	0.000817	0.00532	CbGbCtD
Docetaxel—ABCC2—Paclitaxel—ovarian cancer	0.000798	0.00519	CbGbCtD
Docetaxel—ABCC2—Carboplatin—ovarian cancer	0.000751	0.00488	CbGbCtD
Docetaxel—ABCG2—Paclitaxel—ovarian cancer	0.000721	0.00469	CbGbCtD
Docetaxel—ABCG2—Carboplatin—ovarian cancer	0.000679	0.00442	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—ovarian cancer	0.000581	0.00378	CbGbCtD
Docetaxel—CYP3A7—Paclitaxel—ovarian cancer	0.000533	0.00347	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.000533	0.00347	CbGbCtD
Docetaxel—ABCB1—Topotecan—ovarian cancer	0.000525	0.00342	CbGbCtD
Docetaxel—KIF11—embryo—ovarian cancer	0.00043	0.0303	CbGeAlD
Docetaxel—ABCC2—Doxorubicin—ovarian cancer	0.00043	0.0028	CbGbCtD
Docetaxel—CYP3A5—Paclitaxel—ovarian cancer	0.000399	0.0026	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—ovarian cancer	0.000389	0.00253	CbGbCtD
Docetaxel—ABCB1—Vinorelbine—ovarian cancer	0.00037	0.00241	CbGbCtD
Docetaxel—Cabazitaxel—TUBB3—ovarian cancer	0.000368	0.417	CrCbGaD
Docetaxel—CYP3A4—Topotecan—ovarian cancer	0.000315	0.00205	CbGbCtD
Docetaxel—KIF11—endometrium—ovarian cancer	0.000315	0.0221	CbGeAlD
Docetaxel—TUBB4B—oviduct—ovarian cancer	0.000306	0.0215	CbGeAlD
Docetaxel—Paclitaxel—TUBB3—ovarian cancer	0.000297	0.337	CrCbGaD
Docetaxel—KIF11—Irinotecan—Topotecan—ovarian cancer	0.000293	0.489	CbGdCrCtD
Docetaxel—KIF11—female reproductive system—ovarian cancer	0.000261	0.0183	CbGeAlD
Docetaxel—ABCB1—Paclitaxel—ovarian cancer	0.00026	0.00169	CbGbCtD
Docetaxel—KIF11—bone marrow—ovarian cancer	0.000246	0.0173	CbGeAlD
Docetaxel—KIF11—female gonad—ovarian cancer	0.000237	0.0167	CbGeAlD
Docetaxel—KIF11—vagina—ovarian cancer	0.000236	0.0166	CbGeAlD
Docetaxel—CYP3A4—Vinorelbine—ovarian cancer	0.000222	0.00144	CbGbCtD
Docetaxel—BCL2—Irinotecan—Topotecan—ovarian cancer	0.000212	0.353	CbGdCrCtD
Docetaxel—KIF11—testis—ovarian cancer	0.00021	0.0148	CbGeAlD
Docetaxel—MAP4—embryo—ovarian cancer	0.000198	0.014	CbGeAlD
Docetaxel—MAP2—myometrium—ovarian cancer	0.000162	0.0114	CbGeAlD
Docetaxel—MAP4—uterine cervix—ovarian cancer	0.00016	0.0113	CbGeAlD
Docetaxel—MAP2—embryo—ovarian cancer	0.000156	0.011	CbGeAlD
Docetaxel—CYP3A4—Paclitaxel—ovarian cancer	0.000156	0.00101	CbGbCtD
Docetaxel—MAP4—decidua—ovarian cancer	0.000153	0.0108	CbGeAlD
Docetaxel—KIF11—lymph node—ovarian cancer	0.000152	0.0107	CbGeAlD
Docetaxel—TUBB1—decidua—ovarian cancer	0.000149	0.0105	CbGeAlD
Docetaxel—BCL2—epithelium—ovarian cancer	0.000147	0.0103	CbGeAlD
Docetaxel—EGFR—uterine cervix—ovarian cancer	0.000144	0.0101	CbGeAlD
Docetaxel—TUBB8—testis—ovarian cancer	0.000142	0.01	CbGeAlD
Docetaxel—ABCB1—Doxorubicin—ovarian cancer	0.00014	0.000912	CbGbCtD
Docetaxel—MAP4—gonad—ovarian cancer	0.000135	0.00947	CbGeAlD
Docetaxel—MAP4—uterus—ovarian cancer	0.000134	0.00941	CbGeAlD
Docetaxel—Paclitaxel—CYP1B1—ovarian cancer	0.000133	0.15	CrCbGaD
Docetaxel—BCL2—endometrium—ovarian cancer	0.000132	0.00928	CbGeAlD
Docetaxel—MAP2—uterine cervix—ovarian cancer	0.000126	0.00889	CbGeAlD
Docetaxel—MAPT—testis—ovarian cancer	0.000123	0.00868	CbGeAlD
Docetaxel—BCL2—gonad—ovarian cancer	0.000122	0.00861	CbGeAlD
Docetaxel—BCL2—uterus—ovarian cancer	0.000121	0.00855	CbGeAlD
Docetaxel—TUBB2B—myometrium—ovarian cancer	0.000121	0.00853	CbGeAlD
Docetaxel—TUBB4A—embryo—ovarian cancer	0.000121	0.00849	CbGeAlD
Docetaxel—MAP2—decidua—ovarian cancer	0.00012	0.00847	CbGeAlD
Docetaxel—MAP4—female reproductive system—ovarian cancer	0.00012	0.00846	CbGeAlD
Docetaxel—EGFR—uterus—ovarian cancer	0.00012	0.00845	CbGeAlD
Docetaxel—TUBB—myometrium—ovarian cancer	0.000115	0.00807	CbGeAlD
Docetaxel—MAP2—endometrium—ovarian cancer	0.000114	0.00804	CbGeAlD
Docetaxel—TUBB2A—myometrium—ovarian cancer	0.000114	0.00803	CbGeAlD
Docetaxel—TUBB6—myometrium—ovarian cancer	0.000113	0.00792	CbGeAlD
Docetaxel—TUBB1—bone marrow—ovarian cancer	0.000111	0.00781	CbGeAlD
Docetaxel—MAP4—female gonad—ovarian cancer	0.000109	0.0077	CbGeAlD
Docetaxel—BCL2—female reproductive system—ovarian cancer	0.000109	0.00769	CbGeAlD
Docetaxel—MAP4—vagina—ovarian cancer	0.000109	0.00765	CbGeAlD
Docetaxel—MAP2—gonad—ovarian cancer	0.000106	0.00746	CbGeAlD
Docetaxel—BCL2—bone marrow—ovarian cancer	0.000103	0.00726	CbGeAlD
Docetaxel—BCL2—female gonad—ovarian cancer	9.94e-05	0.007	CbGeAlD
Docetaxel—ABCC10—myometrium—ovarian cancer	9.85e-05	0.00693	CbGeAlD
Docetaxel—EGFR—female gonad—ovarian cancer	9.82e-05	0.00691	CbGeAlD
Docetaxel—TUBB4B—myometrium—ovarian cancer	9.78e-05	0.00688	CbGeAlD
Docetaxel—TUBB4A—uterine cervix—ovarian cancer	9.76e-05	0.00687	CbGeAlD
Docetaxel—MAP4—testis—ovarian cancer	9.7e-05	0.00683	CbGeAlD
Docetaxel—TUBB3—testis—ovarian cancer	9.7e-05	0.00683	CbGeAlD
Docetaxel—SLCO1B3—vagina—ovarian cancer	9.51e-05	0.0067	CbGeAlD
Docetaxel—TUBB1—testis—ovarian cancer	9.48e-05	0.00667	CbGeAlD
Docetaxel—MAP2—female reproductive system—ovarian cancer	9.46e-05	0.00666	CbGeAlD
Docetaxel—KIF11—Vinblastine—Vinorelbine—ovarian cancer	9.44e-05	0.158	CbGdCrCtD
Docetaxel—TUBB2B—uterine cervix—ovarian cancer	9.43e-05	0.00664	CbGeAlD
Docetaxel—TUBB4B—embryo—ovarian cancer	9.41e-05	0.00662	CbGeAlD
Docetaxel—MAPT—lymph node—ovarian cancer	8.94e-05	0.00629	CbGeAlD
Docetaxel—TUBB—uterine cervix—ovarian cancer	8.93e-05	0.00628	CbGeAlD
Docetaxel—TUBB2A—uterine cervix—ovarian cancer	8.88e-05	0.00625	CbGeAlD
Docetaxel—TUBB6—epithelium—ovarian cancer	8.83e-05	0.00622	CbGeAlD
Docetaxel—BCL2—testis—ovarian cancer	8.81e-05	0.0062	CbGeAlD
Docetaxel—TUBB6—uterine cervix—ovarian cancer	8.76e-05	0.00616	CbGeAlD
Docetaxel—EGFR—testis—ovarian cancer	8.71e-05	0.00613	CbGeAlD
Docetaxel—MAP2—female gonad—ovarian cancer	8.61e-05	0.00606	CbGeAlD
Docetaxel—MAP2—vagina—ovarian cancer	8.56e-05	0.00602	CbGeAlD
Docetaxel—TUBB2B—endometrium—ovarian cancer	8.53e-05	0.006	CbGeAlD
Docetaxel—TUBB—decidua—ovarian cancer	8.5e-05	0.00599	CbGeAlD
Docetaxel—TUBB2A—decidua—ovarian cancer	8.46e-05	0.00595	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—ovarian cancer	8.4e-05	0.000546	CbGbCtD
Docetaxel—TUBB6—decidua—ovarian cancer	8.34e-05	0.00587	CbGeAlD
Docetaxel—TUBB4A—gonad—ovarian cancer	8.19e-05	0.00576	CbGeAlD
Docetaxel—TUBB4A—uterus—ovarian cancer	8.13e-05	0.00572	CbGeAlD
Docetaxel—TUBB—endometrium—ovarian cancer	8.07e-05	0.00568	CbGeAlD
Docetaxel—TUBB2A—endometrium—ovarian cancer	8.03e-05	0.00565	CbGeAlD
Docetaxel—TUBB6—endometrium—ovarian cancer	7.92e-05	0.00557	CbGeAlD
Docetaxel—TUBB2B—gonad—ovarian cancer	7.91e-05	0.00557	CbGeAlD
Docetaxel—ABCC10—uterine cervix—ovarian cancer	7.67e-05	0.0054	CbGeAlD
Docetaxel—MAP2—testis—ovarian cancer	7.64e-05	0.00537	CbGeAlD
Docetaxel—TUBB4B—uterine cervix—ovarian cancer	7.61e-05	0.00536	CbGeAlD
Docetaxel—TUBB—uterus—ovarian cancer	7.44e-05	0.00524	CbGeAlD
Docetaxel—TUBB2A—uterus—ovarian cancer	7.4e-05	0.00521	CbGeAlD
Docetaxel—TUBB6—gonad—ovarian cancer	7.35e-05	0.00517	CbGeAlD
Docetaxel—TUBB4A—female reproductive system—ovarian cancer	7.31e-05	0.00515	CbGeAlD
Docetaxel—ABCC10—decidua—ovarian cancer	7.3e-05	0.00514	CbGeAlD
Docetaxel—TUBB6—uterus—ovarian cancer	7.3e-05	0.00514	CbGeAlD
Docetaxel—TUBB4B—decidua—ovarian cancer	7.25e-05	0.0051	CbGeAlD
Docetaxel—TUBB2B—female reproductive system—ovarian cancer	7.07e-05	0.00497	CbGeAlD
Docetaxel—MAP4—lymph node—ovarian cancer	7.03e-05	0.00495	CbGeAlD
Docetaxel—ABCC1—myometrium—ovarian cancer	6.97e-05	0.0049	CbGeAlD
Docetaxel—ABCC10—endometrium—ovarian cancer	6.93e-05	0.00488	CbGeAlD
Docetaxel—TUBB4B—endometrium—ovarian cancer	6.88e-05	0.00485	CbGeAlD
Docetaxel—TUBB4A—female gonad—ovarian cancer	6.65e-05	0.00468	CbGeAlD
Docetaxel—TUBB2A—female reproductive system—ovarian cancer	6.65e-05	0.00468	CbGeAlD
Docetaxel—SLC22A7—testis—ovarian cancer	6.6e-05	0.00465	CbGeAlD
Docetaxel—TUBB6—female reproductive system—ovarian cancer	6.56e-05	0.00462	CbGeAlD
Docetaxel—ABCC10—gonad—ovarian cancer	6.43e-05	0.00453	CbGeAlD
Docetaxel—TUBB2B—female gonad—ovarian cancer	6.43e-05	0.00453	CbGeAlD
Docetaxel—TUBB2B—vagina—ovarian cancer	6.39e-05	0.0045	CbGeAlD
Docetaxel—ABCC10—uterus—ovarian cancer	6.39e-05	0.0045	CbGeAlD
Docetaxel—BCL2—lymph node—ovarian cancer	6.39e-05	0.0045	CbGeAlD
Docetaxel—TUBB4B—gonad—ovarian cancer	6.39e-05	0.00449	CbGeAlD
Docetaxel—TUBB4B—uterus—ovarian cancer	6.34e-05	0.00447	CbGeAlD
Docetaxel—EGFR—lymph node—ovarian cancer	6.31e-05	0.00444	CbGeAlD
Docetaxel—TUBB—bone marrow—ovarian cancer	6.31e-05	0.00444	CbGeAlD
Docetaxel—TUBB2A—bone marrow—ovarian cancer	6.28e-05	0.00442	CbGeAlD
Docetaxel—TUBB6—bone marrow—ovarian cancer	6.19e-05	0.00436	CbGeAlD
Docetaxel—TUBB—female gonad—ovarian cancer	6.08e-05	0.00428	CbGeAlD
Docetaxel—TUBB2A—female gonad—ovarian cancer	6.05e-05	0.00426	CbGeAlD
Docetaxel—TUBB—vagina—ovarian cancer	6.05e-05	0.00426	CbGeAlD
Docetaxel—TUBB2A—vagina—ovarian cancer	6.02e-05	0.00423	CbGeAlD
Docetaxel—TUBB6—female gonad—ovarian cancer	5.97e-05	0.0042	CbGeAlD
Docetaxel—TUBB6—vagina—ovarian cancer	5.93e-05	0.00418	CbGeAlD
Docetaxel—TUBB4A—testis—ovarian cancer	5.9e-05	0.00415	CbGeAlD
Docetaxel—ABCG2—myometrium—ovarian cancer	5.77e-05	0.00406	CbGeAlD
Docetaxel—ABCC10—female reproductive system—ovarian cancer	5.74e-05	0.00404	CbGeAlD
Docetaxel—CYP1B1—decidua—ovarian cancer	5.74e-05	0.00404	CbGeAlD
Docetaxel—TUBB2B—testis—ovarian cancer	5.7e-05	0.00401	CbGeAlD
Docetaxel—TUBB4B—female reproductive system—ovarian cancer	5.7e-05	0.00401	CbGeAlD
Docetaxel—MAP2—lymph node—ovarian cancer	5.53e-05	0.0039	CbGeAlD
Docetaxel—ABCC10—bone marrow—ovarian cancer	5.42e-05	0.00382	CbGeAlD
Docetaxel—ABCC1—uterine cervix—ovarian cancer	5.42e-05	0.00382	CbGeAlD
Docetaxel—TUBB—testis—ovarian cancer	5.4e-05	0.0038	CbGeAlD
Docetaxel—TUBB4B—bone marrow—ovarian cancer	5.38e-05	0.00379	CbGeAlD
Docetaxel—TUBB2A—testis—ovarian cancer	5.37e-05	0.00378	CbGeAlD
Docetaxel—TUBB6—testis—ovarian cancer	5.29e-05	0.00373	CbGeAlD
Docetaxel—ABCC10—female gonad—ovarian cancer	5.23e-05	0.00368	CbGeAlD
Docetaxel—ABCC10—vagina—ovarian cancer	5.2e-05	0.00366	CbGeAlD
Docetaxel—TUBB4B—female gonad—ovarian cancer	5.19e-05	0.00365	CbGeAlD
Docetaxel—ABCC1—decidua—ovarian cancer	5.17e-05	0.00364	CbGeAlD
Docetaxel—TUBB4B—vagina—ovarian cancer	5.16e-05	0.00363	CbGeAlD
Docetaxel—CYP1B1—gonad—ovarian cancer	5.06e-05	0.00356	CbGeAlD
Docetaxel—CYP1B1—uterus—ovarian cancer	5.02e-05	0.00354	CbGeAlD
Docetaxel—ABCC1—endometrium—ovarian cancer	4.9e-05	0.00345	CbGeAlD
Docetaxel—Cabazitaxel—ABCB1—ovarian cancer	4.71e-05	0.0534	CrCbGaD
Docetaxel—ABCC10—testis—ovarian cancer	4.64e-05	0.00326	CbGeAlD
Docetaxel—ABCC2—female reproductive system—ovarian cancer	4.61e-05	0.00325	CbGeAlD
Docetaxel—TUBB4B—testis—ovarian cancer	4.6e-05	0.00324	CbGeAlD
Docetaxel—ABCC1—uterus—ovarian cancer	4.52e-05	0.00318	CbGeAlD
Docetaxel—CYP1B1—female reproductive system—ovarian cancer	4.52e-05	0.00318	CbGeAlD
Docetaxel—ABCG2—uterine cervix—ovarian cancer	4.49e-05	0.00316	CbGeAlD
Docetaxel—ABCG2—decidua—ovarian cancer	4.28e-05	0.00301	CbGeAlD
Docetaxel—TUBB4A—lymph node—ovarian cancer	4.28e-05	0.00301	CbGeAlD
Docetaxel—CYP3A5—uterine cervix—ovarian cancer	4.17e-05	0.00293	CbGeAlD
Docetaxel—TUBB2B—lymph node—ovarian cancer	4.13e-05	0.00291	CbGeAlD
Docetaxel—CYP1B1—female gonad—ovarian cancer	4.11e-05	0.00289	CbGeAlD
Docetaxel—ABCG2—endometrium—ovarian cancer	4.06e-05	0.00286	CbGeAlD
Docetaxel—TUBB—lymph node—ovarian cancer	3.91e-05	0.00275	CbGeAlD
Docetaxel—TUBB2A—lymph node—ovarian cancer	3.89e-05	0.00274	CbGeAlD
Docetaxel—TUBB6—lymph node—ovarian cancer	3.84e-05	0.0027	CbGeAlD
Docetaxel—Paclitaxel—ABCB1—ovarian cancer	3.81e-05	0.0431	CrCbGaD
Docetaxel—ABCG2—uterus—ovarian cancer	3.74e-05	0.00263	CbGeAlD
Docetaxel—ABCC2—testis—ovarian cancer	3.72e-05	0.00262	CbGeAlD
Docetaxel—ABCC1—female gonad—ovarian cancer	3.7e-05	0.0026	CbGeAlD
Docetaxel—ABCC1—vagina—ovarian cancer	3.67e-05	0.00259	CbGeAlD
Docetaxel—CYP1B1—testis—ovarian cancer	3.65e-05	0.00257	CbGeAlD
Docetaxel—ABCC10—lymph node—ovarian cancer	3.36e-05	0.00237	CbGeAlD
Docetaxel—TUBB4B—lymph node—ovarian cancer	3.34e-05	0.00235	CbGeAlD
Docetaxel—ABCC1—testis—ovarian cancer	3.28e-05	0.00231	CbGeAlD
Docetaxel—ABCG2—bone marrow—ovarian cancer	3.18e-05	0.00224	CbGeAlD
Docetaxel—ABCG2—female gonad—ovarian cancer	3.06e-05	0.00215	CbGeAlD
Docetaxel—ABCG2—vagina—ovarian cancer	3.04e-05	0.00214	CbGeAlD
Docetaxel—ABCB1—myometrium—ovarian cancer	2.84e-05	0.002	CbGeAlD
Docetaxel—CYP3A5—female gonad—ovarian cancer	2.84e-05	0.002	CbGeAlD
Docetaxel—CYP3A5—vagina—ovarian cancer	2.82e-05	0.00199	CbGeAlD
Docetaxel—ABCB1—embryo—ovarian cancer	2.74e-05	0.00193	CbGeAlD
Docetaxel—ABCG2—testis—ovarian cancer	2.71e-05	0.00191	CbGeAlD
Docetaxel—ABCC2—lymph node—ovarian cancer	2.7e-05	0.0019	CbGeAlD
Docetaxel—CYP1B1—lymph node—ovarian cancer	2.64e-05	0.00186	CbGeAlD
Docetaxel—ABCC1—lymph node—ovarian cancer	2.38e-05	0.00167	CbGeAlD
Docetaxel—CYP3A4—female reproductive system—ovarian cancer	2.34e-05	0.00165	CbGeAlD
Docetaxel—ABCB1—epithelium—ovarian cancer	2.23e-05	0.00157	CbGeAlD
Docetaxel—ABCB1—uterine cervix—ovarian cancer	2.21e-05	0.00156	CbGeAlD
Docetaxel—ABCB1—decidua—ovarian cancer	2.11e-05	0.00148	CbGeAlD
Docetaxel—ABCB1—endometrium—ovarian cancer	2e-05	0.00141	CbGeAlD
Docetaxel—ABCG2—lymph node—ovarian cancer	1.97e-05	0.00138	CbGeAlD
Docetaxel—ABCB1—gonad—ovarian cancer	1.86e-05	0.00131	CbGeAlD
Docetaxel—ABCB1—uterus—ovarian cancer	1.85e-05	0.0013	CbGeAlD
Docetaxel—ABCB1—female reproductive system—ovarian cancer	1.66e-05	0.00117	CbGeAlD
Docetaxel—ABCB1—bone marrow—ovarian cancer	1.57e-05	0.0011	CbGeAlD
Docetaxel—ABCB1—female gonad—ovarian cancer	1.51e-05	0.00106	CbGeAlD
Docetaxel—ABCB1—vagina—ovarian cancer	1.5e-05	0.00106	CbGeAlD
Docetaxel—ABCB1—testis—ovarian cancer	1.34e-05	0.000942	CbGeAlD
Docetaxel—ABCB1—lymph node—ovarian cancer	9.7e-06	0.000683	CbGeAlD
Docetaxel—Arthralgia—Paclitaxel—ovarian cancer	9.58e-06	0.000292	CcSEcCtD
Docetaxel—Myalgia—Paclitaxel—ovarian cancer	9.58e-06	0.000292	CcSEcCtD
Docetaxel—Nasopharyngitis—Epirubicin—ovarian cancer	9.55e-06	0.000292	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	9.51e-06	0.00029	CcSEcCtD
Docetaxel—Nausea—Topotecan—ovarian cancer	9.48e-06	0.000289	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Epirubicin—ovarian cancer	9.42e-06	0.000288	CcSEcCtD
Docetaxel—Dry mouth—Paclitaxel—ovarian cancer	9.37e-06	0.000286	CcSEcCtD
Docetaxel—Diarrhoea—Vinorelbine—ovarian cancer	9.34e-06	0.000285	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—ovarian cancer	9.29e-06	0.000284	CcSEcCtD
Docetaxel—Nausea—Melphalan—ovarian cancer	9.28e-06	0.000283	CcSEcCtD
Docetaxel—Confusional state—Paclitaxel—ovarian cancer	9.26e-06	0.000283	CcSEcCtD
Docetaxel—Dysphagia—Epirubicin—ovarian cancer	9.23e-06	0.000282	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—ovarian cancer	9.19e-06	0.000281	CcSEcCtD
Docetaxel—Anaphylactic shock—Paclitaxel—ovarian cancer	9.18e-06	0.00028	CcSEcCtD
Docetaxel—Oedema—Paclitaxel—ovarian cancer	9.18e-06	0.00028	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—ovarian cancer	9.12e-06	0.000279	CcSEcCtD
Docetaxel—Infection—Paclitaxel—ovarian cancer	9.12e-06	0.000279	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—ovarian cancer	9.06e-06	0.000277	CcSEcCtD
Docetaxel—Shock—Paclitaxel—ovarian cancer	9.03e-06	0.000276	CcSEcCtD
Docetaxel—Dizziness—Vinorelbine—ovarian cancer	9.03e-06	0.000276	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—ovarian cancer	9.02e-06	0.000276	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—ovarian cancer	9.02e-06	0.000276	CcSEcCtD
Docetaxel—Nervous system disorder—Paclitaxel—ovarian cancer	9e-06	0.000275	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—ovarian cancer	8.99e-06	0.000275	CcSEcCtD
Docetaxel—Thrombocytopenia—Paclitaxel—ovarian cancer	8.99e-06	0.000274	CcSEcCtD
Docetaxel—Tachycardia—Paclitaxel—ovarian cancer	8.96e-06	0.000274	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—ovarian cancer	8.93e-06	0.000273	CcSEcCtD
Docetaxel—Skin disorder—Paclitaxel—ovarian cancer	8.92e-06	0.000272	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	8.9e-06	0.000272	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	8.9e-06	0.000272	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—ovarian cancer	8.84e-06	0.00027	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—ovarian cancer	8.77e-06	0.000268	CcSEcCtD
Docetaxel—Anorexia—Paclitaxel—ovarian cancer	8.75e-06	0.000267	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	8.71e-06	0.000266	CcSEcCtD
Docetaxel—Vomiting—Vinorelbine—ovarian cancer	8.68e-06	0.000265	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—ovarian cancer	8.63e-06	0.000264	CcSEcCtD
Docetaxel—Rash—Vinorelbine—ovarian cancer	8.61e-06	0.000263	CcSEcCtD
Docetaxel—Dermatitis—Vinorelbine—ovarian cancer	8.6e-06	0.000263	CcSEcCtD
Docetaxel—Hypotension—Paclitaxel—ovarian cancer	8.58e-06	0.000262	CcSEcCtD
Docetaxel—Headache—Vinorelbine—ovarian cancer	8.55e-06	0.000261	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—ovarian cancer	8.54e-06	0.000261	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—ovarian cancer	8.4e-06	0.000256	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	8.36e-06	0.000255	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—ovarian cancer	8.35e-06	0.000255	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—ovarian cancer	8.32e-06	0.000254	CcSEcCtD
Docetaxel—Insomnia—Paclitaxel—ovarian cancer	8.3e-06	0.000254	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—ovarian cancer	8.28e-06	0.000253	CcSEcCtD
Docetaxel—Paraesthesia—Paclitaxel—ovarian cancer	8.24e-06	0.000252	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—ovarian cancer	8.23e-06	0.000251	CcSEcCtD
Docetaxel—Infestation—Epirubicin—ovarian cancer	8.23e-06	0.000251	CcSEcCtD
Docetaxel—Dyspnoea—Paclitaxel—ovarian cancer	8.18e-06	0.00025	CcSEcCtD
Docetaxel—Somnolence—Paclitaxel—ovarian cancer	8.16e-06	0.000249	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	8.16e-06	0.000249	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—ovarian cancer	8.11e-06	0.000248	CcSEcCtD
Docetaxel—Nausea—Vinorelbine—ovarian cancer	8.11e-06	0.000248	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—ovarian cancer	8.09e-06	0.000247	CcSEcCtD
Docetaxel—Dyspepsia—Paclitaxel—ovarian cancer	8.08e-06	0.000247	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—ovarian cancer	8.07e-06	0.000246	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—ovarian cancer	8.02e-06	0.000245	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—ovarian cancer	8.02e-06	0.000245	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—ovarian cancer	8e-06	0.000244	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—ovarian cancer	7.99e-06	0.000244	CcSEcCtD
Docetaxel—Decreased appetite—Paclitaxel—ovarian cancer	7.98e-06	0.000244	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Paclitaxel—ovarian cancer	7.93e-06	0.000242	CcSEcCtD
Docetaxel—Fatigue—Paclitaxel—ovarian cancer	7.92e-06	0.000242	CcSEcCtD
Docetaxel—Pain—Paclitaxel—ovarian cancer	7.85e-06	0.00024	CcSEcCtD
Docetaxel—Constipation—Paclitaxel—ovarian cancer	7.85e-06	0.00024	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—ovarian cancer	7.78e-06	0.000238	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—ovarian cancer	7.77e-06	0.000237	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—ovarian cancer	7.76e-06	0.000237	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—ovarian cancer	7.73e-06	0.000236	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—ovarian cancer	7.68e-06	0.000235	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—ovarian cancer	7.66e-06	0.000234	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—ovarian cancer	7.61e-06	0.000233	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—ovarian cancer	7.61e-06	0.000233	CcSEcCtD
Docetaxel—Feeling abnormal—Paclitaxel—ovarian cancer	7.57e-06	0.000231	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.55e-06	0.000231	CcSEcCtD
Docetaxel—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.51e-06	0.000229	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—ovarian cancer	7.49e-06	0.000229	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.46e-06	0.000228	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—ovarian cancer	7.43e-06	0.000227	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—ovarian cancer	7.42e-06	0.000227	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—ovarian cancer	7.42e-06	0.000227	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—ovarian cancer	7.41e-06	0.000226	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—ovarian cancer	7.4e-06	0.000226	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—ovarian cancer	7.39e-06	0.000226	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—ovarian cancer	7.39e-06	0.000226	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—ovarian cancer	7.35e-06	0.000224	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—ovarian cancer	7.33e-06	0.000224	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—ovarian cancer	7.3e-06	0.000223	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—ovarian cancer	7.28e-06	0.000222	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—ovarian cancer	7.26e-06	0.000222	CcSEcCtD
Docetaxel—Body temperature increased—Paclitaxel—ovarian cancer	7.26e-06	0.000222	CcSEcCtD
Docetaxel—Abdominal pain—Paclitaxel—ovarian cancer	7.26e-06	0.000222	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—ovarian cancer	7.24e-06	0.000221	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.2e-06	0.00022	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—ovarian cancer	7.18e-06	0.000219	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—ovarian cancer	7.12e-06	0.000217	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—ovarian cancer	7.11e-06	0.000217	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—ovarian cancer	6.99e-06	0.000213	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—ovarian cancer	6.9e-06	0.000211	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—ovarian cancer	6.87e-06	0.00021	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—ovarian cancer	6.86e-06	0.000209	CcSEcCtD
Docetaxel—Flushing—Epirubicin—ovarian cancer	6.86e-06	0.000209	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—ovarian cancer	6.85e-06	0.000209	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—ovarian cancer	6.84e-06	0.000209	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—ovarian cancer	6.84e-06	0.000209	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—ovarian cancer	6.8e-06	0.000208	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—ovarian cancer	6.78e-06	0.000207	CcSEcCtD
Docetaxel—Hypersensitivity—Paclitaxel—ovarian cancer	6.76e-06	0.000207	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—ovarian cancer	6.75e-06	0.000206	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—ovarian cancer	6.73e-06	0.000206	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—ovarian cancer	6.72e-06	0.000205	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—ovarian cancer	6.7e-06	0.000205	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—ovarian cancer	6.7e-06	0.000205	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—ovarian cancer	6.67e-06	0.000204	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—ovarian cancer	6.66e-06	0.000203	CcSEcCtD
Docetaxel—Chills—Epirubicin—ovarian cancer	6.63e-06	0.000202	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—ovarian cancer	6.6e-06	0.000202	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—ovarian cancer	6.59e-06	0.000201	CcSEcCtD
Docetaxel—Asthenia—Paclitaxel—ovarian cancer	6.59e-06	0.000201	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—ovarian cancer	6.53e-06	0.000199	CcSEcCtD
Docetaxel—Pruritus—Paclitaxel—ovarian cancer	6.5e-06	0.000198	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—ovarian cancer	6.47e-06	0.000198	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—ovarian cancer	6.46e-06	0.000197	CcSEcCtD
Docetaxel—Erythema—Epirubicin—ovarian cancer	6.43e-06	0.000196	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—ovarian cancer	6.43e-06	0.000196	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—ovarian cancer	6.39e-06	0.000195	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—ovarian cancer	6.34e-06	0.000194	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—ovarian cancer	6.34e-06	0.000194	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—ovarian cancer	6.3e-06	0.000192	CcSEcCtD
Docetaxel—Diarrhoea—Paclitaxel—ovarian cancer	6.28e-06	0.000192	CcSEcCtD
Docetaxel—Back pain—Epirubicin—ovarian cancer	6.22e-06	0.00019	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—ovarian cancer	6.2e-06	0.000189	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—ovarian cancer	6.18e-06	0.000189	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—ovarian cancer	6.17e-06	0.000189	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—ovarian cancer	6.16e-06	0.000188	CcSEcCtD
Docetaxel—Chills—Doxorubicin—ovarian cancer	6.13e-06	0.000187	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—ovarian cancer	6.11e-06	0.000186	CcSEcCtD
Docetaxel—Dizziness—Paclitaxel—ovarian cancer	6.07e-06	0.000185	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—ovarian cancer	6.04e-06	0.000184	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—ovarian cancer	5.99e-06	0.000183	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—ovarian cancer	5.95e-06	0.000182	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—ovarian cancer	5.95e-06	0.000182	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—ovarian cancer	5.94e-06	0.000182	CcSEcCtD
Docetaxel—Vomiting—Paclitaxel—ovarian cancer	5.84e-06	0.000178	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—ovarian cancer	5.83e-06	0.000178	CcSEcCtD
Docetaxel—Rash—Paclitaxel—ovarian cancer	5.79e-06	0.000177	CcSEcCtD
Docetaxel—Dermatitis—Paclitaxel—ovarian cancer	5.78e-06	0.000177	CcSEcCtD
Docetaxel—Syncope—Epirubicin—ovarian cancer	5.77e-06	0.000176	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—ovarian cancer	5.76e-06	0.000176	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—ovarian cancer	5.76e-06	0.000176	CcSEcCtD
Docetaxel—Headache—Paclitaxel—ovarian cancer	5.75e-06	0.000176	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—ovarian cancer	5.72e-06	0.000175	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—ovarian cancer	5.68e-06	0.000174	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—ovarian cancer	5.65e-06	0.000173	CcSEcCtD
Docetaxel—Cough—Epirubicin—ovarian cancer	5.61e-06	0.000171	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—ovarian cancer	5.57e-06	0.00017	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—ovarian cancer	5.55e-06	0.00017	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—ovarian cancer	5.5e-06	0.000168	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—ovarian cancer	5.48e-06	0.000167	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—ovarian cancer	5.48e-06	0.000167	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—ovarian cancer	5.48e-06	0.000167	CcSEcCtD
Docetaxel—Nausea—Paclitaxel—ovarian cancer	5.45e-06	0.000167	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.44e-06	0.000166	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—ovarian cancer	5.35e-06	0.000164	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—ovarian cancer	5.34e-06	0.000163	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—ovarian cancer	5.33e-06	0.000163	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—ovarian cancer	5.29e-06	0.000162	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—ovarian cancer	5.26e-06	0.000161	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—ovarian cancer	5.25e-06	0.00016	CcSEcCtD
Docetaxel—Oedema—Epirubicin—ovarian cancer	5.25e-06	0.00016	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—ovarian cancer	5.23e-06	0.00016	CcSEcCtD
Docetaxel—Infection—Epirubicin—ovarian cancer	5.21e-06	0.000159	CcSEcCtD
Docetaxel—Cough—Doxorubicin—ovarian cancer	5.19e-06	0.000159	CcSEcCtD
Docetaxel—Shock—Epirubicin—ovarian cancer	5.16e-06	0.000158	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—ovarian cancer	5.16e-06	0.000157	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—ovarian cancer	5.15e-06	0.000157	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—ovarian cancer	5.14e-06	0.000157	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—ovarian cancer	5.14e-06	0.000157	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—ovarian cancer	5.12e-06	0.000156	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—ovarian cancer	5.1e-06	0.000156	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—ovarian cancer	5.07e-06	0.000155	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—ovarian cancer	5.07e-06	0.000155	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—ovarian cancer	5.07e-06	0.000155	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	5.03e-06	0.000154	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—ovarian cancer	5e-06	0.000153	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—ovarian cancer	4.95e-06	0.000151	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—ovarian cancer	4.9e-06	0.00015	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—ovarian cancer	4.9e-06	0.00015	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—ovarian cancer	4.86e-06	0.000148	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—ovarian cancer	4.86e-06	0.000148	CcSEcCtD
Docetaxel—Infection—Doxorubicin—ovarian cancer	4.82e-06	0.000147	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.78e-06	0.000146	CcSEcCtD
Docetaxel—Shock—Doxorubicin—ovarian cancer	4.78e-06	0.000146	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—ovarian cancer	4.76e-06	0.000145	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—ovarian cancer	4.75e-06	0.000145	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—ovarian cancer	4.75e-06	0.000145	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—ovarian cancer	4.74e-06	0.000145	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—ovarian cancer	4.72e-06	0.000144	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—ovarian cancer	4.71e-06	0.000144	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—ovarian cancer	4.68e-06	0.000143	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—ovarian cancer	4.67e-06	0.000142	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—ovarian cancer	4.63e-06	0.000141	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—ovarian cancer	4.62e-06	0.000141	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—ovarian cancer	4.56e-06	0.000139	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—ovarian cancer	4.54e-06	0.000139	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.53e-06	0.000138	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—ovarian cancer	4.53e-06	0.000138	CcSEcCtD
Docetaxel—Pain—Epirubicin—ovarian cancer	4.49e-06	0.000137	CcSEcCtD
Docetaxel—Constipation—Epirubicin—ovarian cancer	4.49e-06	0.000137	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.42e-06	0.000135	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—ovarian cancer	4.39e-06	0.000134	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—ovarian cancer	4.36e-06	0.000133	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—ovarian cancer	4.33e-06	0.000132	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—ovarian cancer	4.33e-06	0.000132	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—ovarian cancer	4.32e-06	0.000132	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—ovarian cancer	4.29e-06	0.000131	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—ovarian cancer	4.27e-06	0.000131	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—ovarian cancer	4.22e-06	0.000129	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.19e-06	0.000128	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—ovarian cancer	4.19e-06	0.000128	CcSEcCtD
Docetaxel—Pain—Doxorubicin—ovarian cancer	4.15e-06	0.000127	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—ovarian cancer	4.15e-06	0.000127	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—ovarian cancer	4.15e-06	0.000127	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—ovarian cancer	4.15e-06	0.000127	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—ovarian cancer	4e-06	0.000122	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.97e-06	0.000121	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—ovarian cancer	3.87e-06	0.000118	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—ovarian cancer	3.84e-06	0.000117	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—ovarian cancer	3.84e-06	0.000117	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—ovarian cancer	3.77e-06	0.000115	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—ovarian cancer	3.71e-06	0.000113	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—ovarian cancer	3.59e-06	0.00011	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—ovarian cancer	3.58e-06	0.000109	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—ovarian cancer	3.48e-06	0.000106	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—ovarian cancer	3.47e-06	0.000106	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—ovarian cancer	3.44e-06	0.000105	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—ovarian cancer	3.34e-06	0.000102	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—ovarian cancer	3.32e-06	0.000101	CcSEcCtD
Docetaxel—Rash—Epirubicin—ovarian cancer	3.31e-06	0.000101	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—ovarian cancer	3.31e-06	0.000101	CcSEcCtD
Docetaxel—Headache—Epirubicin—ovarian cancer	3.29e-06	0.0001	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—ovarian cancer	3.21e-06	9.81e-05	CcSEcCtD
Docetaxel—Nausea—Epirubicin—ovarian cancer	3.12e-06	9.52e-05	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—ovarian cancer	3.09e-06	9.43e-05	CcSEcCtD
Docetaxel—Rash—Doxorubicin—ovarian cancer	3.06e-06	9.35e-05	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—ovarian cancer	3.06e-06	9.34e-05	CcSEcCtD
Docetaxel—Headache—Doxorubicin—ovarian cancer	3.04e-06	9.29e-05	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—ovarian cancer	2.88e-06	8.81e-05	CcSEcCtD
Docetaxel—EGFR—Axon guidance—HRAS—ovarian cancer	9.72e-07	4.74e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—YAP1—ovarian cancer	9.69e-07	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—ovarian cancer	9.63e-07	4.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—ovarian cancer	9.6e-07	4.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TERT—ovarian cancer	9.6e-07	4.68e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	9.58e-07	4.68e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	9.53e-07	4.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—ovarian cancer	9.5e-07	4.64e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—ovarian cancer	9.49e-07	4.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—ovarian cancer	9.48e-07	4.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—ovarian cancer	9.48e-07	4.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6ST—ovarian cancer	9.4e-07	4.59e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ABCB1—ovarian cancer	9.39e-07	4.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—ovarian cancer	9.38e-07	4.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.33e-07	4.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.32e-07	4.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—ovarian cancer	9.3e-07	4.54e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—ovarian cancer	9.24e-07	4.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TYMS—ovarian cancer	9.23e-07	4.5e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—ovarian cancer	9.15e-07	4.47e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ABCB1—ovarian cancer	9.09e-07	4.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK3—ovarian cancer	9.08e-07	4.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TERT—ovarian cancer	9.05e-07	4.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CG—ovarian cancer	9.03e-07	4.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—ovarian cancer	9.01e-07	4.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—ovarian cancer	8.96e-07	4.37e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TYMS—ovarian cancer	8.92e-07	4.36e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPP2R1A—ovarian cancer	8.9e-07	4.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CAV1—ovarian cancer	8.88e-07	4.33e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	8.82e-07	4.31e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.81e-07	4.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAPK1—ovarian cancer	8.64e-07	4.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6ST—ovarian cancer	8.59e-07	4.19e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—ovarian cancer	8.42e-07	4.11e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	8.42e-07	4.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6ST—ovarian cancer	8.42e-07	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—ovarian cancer	8.37e-07	4.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CAV1—ovarian cancer	8.37e-07	4.08e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—ovarian cancer	8.27e-07	4.04e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ABCB1—ovarian cancer	8.27e-07	4.04e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—ovarian cancer	8.25e-07	4.03e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ABCB1—ovarian cancer	8.19e-07	4e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—ovarian cancer	8.16e-07	3.98e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TYMS—ovarian cancer	8.12e-07	3.96e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.09e-07	3.95e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—ovarian cancer	8.09e-07	3.95e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TYMS—ovarian cancer	8.05e-07	3.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—ovarian cancer	8.04e-07	3.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK3—ovarian cancer	8.02e-07	3.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PPP2R1A—ovarian cancer	7.97e-07	3.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CD—ovarian cancer	7.94e-07	3.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6ST—ovarian cancer	7.93e-07	3.87e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK3—ovarian cancer	7.9e-07	3.86e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—FASN—ovarian cancer	7.9e-07	3.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.83e-07	3.82e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC5A5—ovarian cancer	7.77e-07	3.79e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYTB—ovarian cancer	7.68e-07	3.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK1—ovarian cancer	7.63e-07	3.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—ovarian cancer	7.62e-07	3.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—ovarian cancer	7.6e-07	3.71e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK1—ovarian cancer	7.52e-07	3.67e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—ovarian cancer	7.51e-07	3.67e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A1—ovarian cancer	7.5e-07	3.66e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAV1—ovarian cancer	7.43e-07	3.63e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	7.34e-07	3.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—YAP1—ovarian cancer	7.31e-07	3.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CD—ovarian cancer	7.26e-07	3.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—ovarian cancer	7.21e-07	3.52e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP1B1—ovarian cancer	7.19e-07	3.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAV1—ovarian cancer	7.19e-07	3.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CD—ovarian cancer	7.11e-07	3.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.1e-07	3.47e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—ovarian cancer	7.1e-07	3.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—ovarian cancer	6.94e-07	3.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CB—ovarian cancer	6.92e-07	3.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—ovarian cancer	6.92e-07	3.38e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.87e-07	3.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—ovarian cancer	6.77e-07	3.31e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.71e-07	3.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.71e-07	3.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CD—ovarian cancer	6.7e-07	3.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—ovarian cancer	6.65e-07	3.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—ovarian cancer	6.64e-07	3.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—ovarian cancer	6.62e-07	3.23e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.61e-07	3.23e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—ovarian cancer	6.55e-07	3.2e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAV1—ovarian cancer	6.54e-07	3.19e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—ovarian cancer	6.52e-07	3.18e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAV1—ovarian cancer	6.48e-07	3.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—ovarian cancer	6.41e-07	3.13e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	6.38e-07	3.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—ovarian cancer	6.36e-07	3.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—ovarian cancer	6.36e-07	3.1e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—ovarian cancer	6.34e-07	3.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—ovarian cancer	6.33e-07	3.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—ovarian cancer	6.33e-07	3.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CB—ovarian cancer	6.33e-07	3.09e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—ovarian cancer	6.28e-07	3.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—ovarian cancer	6.2e-07	3.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CB—ovarian cancer	6.2e-07	3.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—ovarian cancer	6.12e-07	2.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—ovarian cancer	6.12e-07	2.99e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—ovarian cancer	6.03e-07	2.95e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FASN—ovarian cancer	5.96e-07	2.91e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—ovarian cancer	5.96e-07	2.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CD—ovarian cancer	5.95e-07	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—ovarian cancer	5.94e-07	2.9e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCB1—ovarian cancer	5.92e-07	2.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—ovarian cancer	5.92e-07	2.89e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—ovarian cancer	5.91e-07	2.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—ovarian cancer	5.88e-07	2.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—ovarian cancer	5.86e-07	2.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.86e-07	2.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CAV1—ovarian cancer	5.86e-07	2.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CB—ovarian cancer	5.84e-07	2.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—ovarian cancer	5.84e-07	2.85e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TYMS—ovarian cancer	5.82e-07	2.84e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—ovarian cancer	5.81e-07	2.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—ovarian cancer	5.81e-07	2.84e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—ovarian cancer	5.78e-07	2.82e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CD—ovarian cancer	5.76e-07	2.81e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.66e-07	2.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—ovarian cancer	5.65e-07	2.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—ovarian cancer	5.61e-07	2.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6ST—ovarian cancer	5.55e-07	2.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—ovarian cancer	5.49e-07	2.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—ovarian cancer	5.48e-07	2.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—ovarian cancer	5.47e-07	2.67e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.43e-07	2.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—ovarian cancer	5.41e-07	2.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—ovarian cancer	5.35e-07	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—ovarian cancer	5.34e-07	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—ovarian cancer	5.34e-07	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—ovarian cancer	5.34e-07	2.61e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—ovarian cancer	5.33e-07	2.6e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CD—ovarian cancer	5.24e-07	2.56e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—ovarian cancer	5.19e-07	2.54e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.19e-07	2.53e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.19e-07	2.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—ovarian cancer	5.18e-07	2.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—ovarian cancer	5.11e-07	2.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—ovarian cancer	5.05e-07	2.46e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CB—ovarian cancer	5.02e-07	2.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—ovarian cancer	4.89e-07	2.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—ovarian cancer	4.88e-07	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK1—ovarian cancer	4.86e-07	2.37e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.81e-07	2.35e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—ovarian cancer	4.79e-07	2.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—ovarian cancer	4.78e-07	2.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CD—ovarian cancer	4.69e-07	2.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAV1—ovarian cancer	4.69e-07	2.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—ovarian cancer	4.67e-07	2.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—ovarian cancer	4.59e-07	2.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—ovarian cancer	4.57e-07	2.23e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CB—ovarian cancer	4.57e-07	2.23e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.53e-07	2.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—ovarian cancer	4.51e-07	2.2e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—YAP1—ovarian cancer	4.5e-07	2.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—ovarian cancer	4.5e-07	2.2e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—ovarian cancer	4.48e-07	2.19e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	4.47e-07	2.18e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—ovarian cancer	4.45e-07	2.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK1—ovarian cancer	4.44e-07	2.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TYMS—ovarian cancer	4.39e-07	2.14e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK1—ovarian cancer	4.35e-07	2.12e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—ovarian cancer	4.35e-07	2.12e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—ovarian cancer	4.34e-07	2.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—ovarian cancer	4.31e-07	2.1e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.27e-07	2.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—ovarian cancer	4.22e-07	2.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—ovarian cancer	4.2e-07	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—ovarian cancer	4.19e-07	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—ovarian cancer	4.14e-07	2.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—ovarian cancer	4.11e-07	2.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK1—ovarian cancer	4.1e-07	2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—ovarian cancer	4.09e-07	2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CB—ovarian cancer	4.09e-07	2e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—ovarian cancer	3.95e-07	1.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—ovarian cancer	3.93e-07	1.92e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—ovarian cancer	3.91e-07	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—ovarian cancer	3.9e-07	1.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—ovarian cancer	3.87e-07	1.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—ovarian cancer	3.86e-07	1.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—ovarian cancer	3.84e-07	1.87e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—ovarian cancer	3.78e-07	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—ovarian cancer	3.76e-07	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—ovarian cancer	3.76e-07	1.83e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.75e-07	1.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—ovarian cancer	3.74e-07	1.82e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FASN—ovarian cancer	3.67e-07	1.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—ovarian cancer	3.66e-07	1.79e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—ovarian cancer	3.65e-07	1.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—ovarian cancer	3.63e-07	1.77e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.61e-07	1.76e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—ovarian cancer	3.57e-07	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—ovarian cancer	3.56e-07	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—ovarian cancer	3.55e-07	1.74e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAV1—ovarian cancer	3.54e-07	1.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—ovarian cancer	3.53e-07	1.73e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—ovarian cancer	3.49e-07	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.49e-07	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—ovarian cancer	3.45e-07	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—ovarian cancer	3.41e-07	1.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—ovarian cancer	3.34e-07	1.63e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.34e-07	1.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—ovarian cancer	3.29e-07	1.61e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.27e-07	1.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.22e-07	1.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—ovarian cancer	3.19e-07	1.56e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.16e-07	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—ovarian cancer	3.16e-07	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—ovarian cancer	3.15e-07	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—ovarian cancer	3.15e-07	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—ovarian cancer	3.15e-07	1.54e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—ovarian cancer	3.09e-07	1.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—ovarian cancer	3.06e-07	1.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—ovarian cancer	3.02e-07	1.47e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.97e-07	1.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—ovarian cancer	2.94e-07	1.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—ovarian cancer	2.91e-07	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK1—ovarian cancer	2.87e-07	1.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.83e-07	1.38e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—ovarian cancer	2.83e-07	1.38e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—ovarian cancer	2.78e-07	1.36e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.76e-07	1.35e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.75e-07	1.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—ovarian cancer	2.71e-07	1.32e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TYMS—ovarian cancer	2.7e-07	1.32e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—ovarian cancer	2.58e-07	1.26e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—ovarian cancer	2.5e-07	1.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—ovarian cancer	2.49e-07	1.22e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.47e-07	1.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—ovarian cancer	2.41e-07	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—ovarian cancer	2.31e-07	1.13e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—ovarian cancer	2.27e-07	1.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—ovarian cancer	2.25e-07	1.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—ovarian cancer	2.21e-07	1.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAV1—ovarian cancer	2.18e-07	1.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—ovarian cancer	2.13e-07	1.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—ovarian cancer	2.04e-07	9.94e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.99e-07	9.73e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.98e-07	9.69e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.74e-07	8.52e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—ovarian cancer	1.63e-07	7.95e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.52e-07	7.42e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.5e-07	7.35e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—ovarian cancer	1.31e-07	6.42e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—ovarian cancer	1.23e-07	6e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.27e-08	4.53e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—ovarian cancer	7.57e-08	3.7e-06	CbGpPWpGaD
